Cargando…

A multimodal protocol utilizing liposomal bupivacaine rib blocks leads to opioid reduction in patients undergoing the Nuss procedure

BACKGROUND: A major challenge associated with the Nuss procedure for pectus excavatum repair is postoperative pain control. Early Recovery Program (ERP) protocols for the Nuss procedure are becoming common, but there is a paucity of experience using liposomal bupivacaine (LB), a long-acting local an...

Descripción completa

Detalles Bibliográficos
Autores principales: Eubanks, Alicia L., Grabski, David F., Pollack, Jessica, Levin, Daniel E., McGahren, Eugene, Martin, Linda W., Gander, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662494/
https://www.ncbi.nlm.nih.gov/pubmed/34992816
http://dx.doi.org/10.21037/jtd-21-1314
_version_ 1784613450044932096
author Eubanks, Alicia L.
Grabski, David F.
Pollack, Jessica
Levin, Daniel E.
McGahren, Eugene
Martin, Linda W.
Gander, Jeffrey
author_facet Eubanks, Alicia L.
Grabski, David F.
Pollack, Jessica
Levin, Daniel E.
McGahren, Eugene
Martin, Linda W.
Gander, Jeffrey
author_sort Eubanks, Alicia L.
collection PubMed
description BACKGROUND: A major challenge associated with the Nuss procedure for pectus excavatum repair is postoperative pain control. Early Recovery Program (ERP) protocols for the Nuss procedure are becoming common, but there is a paucity of experience using liposomal bupivacaine (LB), a long-acting local anesthetic, for rib blocks in this setting. We investigated whether a protocol utilizing LB rib blocks decreased opioid use after the Nuss procedure while achieving equivalent pain control. METHODS: All adolescent patients undergoing the Nuss procedure at our institution between January 2013 and January 2021 were included. Patients were divided into a pre-intervention cohort (n=15), a transition cohort (n=4), and a post-intervention cohort (n=13). Patients in all groups received scheduled acetaminophen and non-steroidals postoperatively. The pre-intervention cohort received an opioid patient-controlled analgesia (PCA) pump postoperatively, with a transition to oral opiates. The transition and post-intervention cohorts received scheduled gabapentin in addition to intraoperative bilateral rib blocks with longer-acting local anesthetic. Rib blocks were performed using 0.25% Bupivacaine in the pre-intervention group. In the transition group, epinephrine (1 mg/kg) was added to 0.25% bupivacaine for the rib block. Following approval in patients aged 13–18 years, 1.3% LB (2.25 mg/kg) was given for a rib block in the post-intervention cohort. RESULTS: Demographic and clinical variables were equivalent in all groups. Post-intervention patients received 90% fewer opioids [median morphine equivalent (MME) mg/kg] compared to the pre-intervention cohort (0.8 vs. 8.2 MME mg/kg, P<0.0001), with no significant difference in pain scores between groups. Hospital length of stay was decreased among the intervention cohort (3 vs. 4 days, P=0.002). CONCLUSIONS: Significant decreases in opioid use and length of stay after the Nuss procedure were achieved by the implementation of a multimodal ERP for pain management, without increase in patient-reported pain scores.
format Online
Article
Text
id pubmed-8662494
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-86624942022-01-05 A multimodal protocol utilizing liposomal bupivacaine rib blocks leads to opioid reduction in patients undergoing the Nuss procedure Eubanks, Alicia L. Grabski, David F. Pollack, Jessica Levin, Daniel E. McGahren, Eugene Martin, Linda W. Gander, Jeffrey J Thorac Dis Original Article BACKGROUND: A major challenge associated with the Nuss procedure for pectus excavatum repair is postoperative pain control. Early Recovery Program (ERP) protocols for the Nuss procedure are becoming common, but there is a paucity of experience using liposomal bupivacaine (LB), a long-acting local anesthetic, for rib blocks in this setting. We investigated whether a protocol utilizing LB rib blocks decreased opioid use after the Nuss procedure while achieving equivalent pain control. METHODS: All adolescent patients undergoing the Nuss procedure at our institution between January 2013 and January 2021 were included. Patients were divided into a pre-intervention cohort (n=15), a transition cohort (n=4), and a post-intervention cohort (n=13). Patients in all groups received scheduled acetaminophen and non-steroidals postoperatively. The pre-intervention cohort received an opioid patient-controlled analgesia (PCA) pump postoperatively, with a transition to oral opiates. The transition and post-intervention cohorts received scheduled gabapentin in addition to intraoperative bilateral rib blocks with longer-acting local anesthetic. Rib blocks were performed using 0.25% Bupivacaine in the pre-intervention group. In the transition group, epinephrine (1 mg/kg) was added to 0.25% bupivacaine for the rib block. Following approval in patients aged 13–18 years, 1.3% LB (2.25 mg/kg) was given for a rib block in the post-intervention cohort. RESULTS: Demographic and clinical variables were equivalent in all groups. Post-intervention patients received 90% fewer opioids [median morphine equivalent (MME) mg/kg] compared to the pre-intervention cohort (0.8 vs. 8.2 MME mg/kg, P<0.0001), with no significant difference in pain scores between groups. Hospital length of stay was decreased among the intervention cohort (3 vs. 4 days, P=0.002). CONCLUSIONS: Significant decreases in opioid use and length of stay after the Nuss procedure were achieved by the implementation of a multimodal ERP for pain management, without increase in patient-reported pain scores. AME Publishing Company 2021-11 /pmc/articles/PMC8662494/ /pubmed/34992816 http://dx.doi.org/10.21037/jtd-21-1314 Text en 2021 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Eubanks, Alicia L.
Grabski, David F.
Pollack, Jessica
Levin, Daniel E.
McGahren, Eugene
Martin, Linda W.
Gander, Jeffrey
A multimodal protocol utilizing liposomal bupivacaine rib blocks leads to opioid reduction in patients undergoing the Nuss procedure
title A multimodal protocol utilizing liposomal bupivacaine rib blocks leads to opioid reduction in patients undergoing the Nuss procedure
title_full A multimodal protocol utilizing liposomal bupivacaine rib blocks leads to opioid reduction in patients undergoing the Nuss procedure
title_fullStr A multimodal protocol utilizing liposomal bupivacaine rib blocks leads to opioid reduction in patients undergoing the Nuss procedure
title_full_unstemmed A multimodal protocol utilizing liposomal bupivacaine rib blocks leads to opioid reduction in patients undergoing the Nuss procedure
title_short A multimodal protocol utilizing liposomal bupivacaine rib blocks leads to opioid reduction in patients undergoing the Nuss procedure
title_sort multimodal protocol utilizing liposomal bupivacaine rib blocks leads to opioid reduction in patients undergoing the nuss procedure
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662494/
https://www.ncbi.nlm.nih.gov/pubmed/34992816
http://dx.doi.org/10.21037/jtd-21-1314
work_keys_str_mv AT eubanksalicial amultimodalprotocolutilizingliposomalbupivacaineribblocksleadstoopioidreductioninpatientsundergoingthenussprocedure
AT grabskidavidf amultimodalprotocolutilizingliposomalbupivacaineribblocksleadstoopioidreductioninpatientsundergoingthenussprocedure
AT pollackjessica amultimodalprotocolutilizingliposomalbupivacaineribblocksleadstoopioidreductioninpatientsundergoingthenussprocedure
AT levindaniele amultimodalprotocolutilizingliposomalbupivacaineribblocksleadstoopioidreductioninpatientsundergoingthenussprocedure
AT mcgahreneugene amultimodalprotocolutilizingliposomalbupivacaineribblocksleadstoopioidreductioninpatientsundergoingthenussprocedure
AT martinlindaw amultimodalprotocolutilizingliposomalbupivacaineribblocksleadstoopioidreductioninpatientsundergoingthenussprocedure
AT ganderjeffrey amultimodalprotocolutilizingliposomalbupivacaineribblocksleadstoopioidreductioninpatientsundergoingthenussprocedure
AT eubanksalicial multimodalprotocolutilizingliposomalbupivacaineribblocksleadstoopioidreductioninpatientsundergoingthenussprocedure
AT grabskidavidf multimodalprotocolutilizingliposomalbupivacaineribblocksleadstoopioidreductioninpatientsundergoingthenussprocedure
AT pollackjessica multimodalprotocolutilizingliposomalbupivacaineribblocksleadstoopioidreductioninpatientsundergoingthenussprocedure
AT levindaniele multimodalprotocolutilizingliposomalbupivacaineribblocksleadstoopioidreductioninpatientsundergoingthenussprocedure
AT mcgahreneugene multimodalprotocolutilizingliposomalbupivacaineribblocksleadstoopioidreductioninpatientsundergoingthenussprocedure
AT martinlindaw multimodalprotocolutilizingliposomalbupivacaineribblocksleadstoopioidreductioninpatientsundergoingthenussprocedure
AT ganderjeffrey multimodalprotocolutilizingliposomalbupivacaineribblocksleadstoopioidreductioninpatientsundergoingthenussprocedure